- Home
- FVCB vs FDMT Comparison
FVCB vs FDMT Comparison
Compare FVCB & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVCB
- FDMT
- Stock Information
- Founded
- FVCB 2007
- FDMT 2013
- Country
- FVCB United States
- FDMT United States
- Employees
- FVCB N/A
- FDMT N/A
- Industry
- FVCB Major Banks
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- FVCB Finance
- FDMT Health Care
- Exchange
- FVCB Nasdaq
- FDMT Nasdaq
- Market Cap
- FVCB 204.0M
- FDMT 192.2M
- IPO Year
- FVCB N/A
- FDMT 2020
- Fundamental
- Price
- FVCB $13.37
- FDMT $7.27
- Analyst Decision
- FVCB Buy
- FDMT Buy
- Analyst Count
- FVCB 1
- FDMT 9
- Target Price
- FVCB $16.00
- FDMT $30.63
- AVG Volume (30 Days)
- FVCB 40.6K
- FDMT 750.8K
- Earning Date
- FVCB 10-21-2025
- FDMT 08-11-2025
- Dividend Yield
- FVCB 1.79%
- FDMT N/A
- EPS Growth
- FVCB 359.39
- FDMT N/A
- EPS
- FVCB 1.11
- FDMT N/A
- Revenue
- FVCB $62,780,000.00
- FDMT $33,000.00
- Revenue This Year
- FVCB $10.08
- FDMT $9,921.62
- Revenue Next Year
- FVCB $7.22
- FDMT N/A
- P/E Ratio
- FVCB $12.06
- FDMT N/A
- Revenue Growth
- FVCB 40.73
- FDMT N/A
- 52 Week Low
- FVCB $9.49
- FDMT $2.24
- 52 Week High
- FVCB $14.50
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- FVCB 54.98
- FDMT 64.99
- Support Level
- FVCB $13.35
- FDMT $6.09
- Resistance Level
- FVCB $13.73
- FDMT $7.33
- Average True Range (ATR)
- FVCB 0.32
- FDMT 0.50
- MACD
- FVCB 0.01
- FDMT -0.06
- Stochastic Oscillator
- FVCB 64.42
- FDMT 80.25
About FVCB FVCBankcorp Inc.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.